Four HMS Faculty Appointed to HHMIFour HMS faculty members are among the The new group of HHMI investigators which includes 10 current HHMI Early Career Scientists -- were selected from a group of 1,155 applicants. HHMI has a very simple mission, said HHMI President Robert Tjian in ... Harvard Medical School, 1 week ago |
(3) images for "harvard bone marrow initiative" | ||||
Making Babies: Selling Embryos, Despite Ethical Concerns, Addresses Genuine NeedsAs the Genetic Literacy Project reports, the desire for infertile couples to have children is not a crime against nature, as fringe responsible genetics organizations argue. The latest round of ethical contretemps is an intriguing April article in ... Forbes.com, 1 week ago
Walking the ethical edge: Made-to-order embryos address genuine needs
American Enterprise Institute, 1 week ago
|
Two California Students Named among America's Top 10 Youth Volunteers of the YearAllyson Ahlstrom, 17, of Santa Rosa, and Teagan Stedman, 13, of Thousand Oaks, were selected as two of America's top 10 youth volunteers of 2013 today by The Prudential Spirit of Community Awards during the program's 18th annual national award ... OSIX News, 1 week ago
|
SOLIGENIX, INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSThe following discussion and analysis provides information to explain our results of operations and financial condition. You should also read our unaudited consolidated interim financial statements and their notes included in this Form 10-Q, and our ... Pharmacy Choice, 2 weeks ago
|
Emil Tom Frei III, MD, Eternal Optimist and Father of Combination Chemotherapy, DiesBOSTON--(BUSINESS WIRE)-- Emil Tom Frei III, MD, former physician-in-chief and director of Dana-Farber Cancer Institute, has died. His work helped bring about the first complete cures for pediatric leukemia patients and led to more effective ... Street Insider, 2 weeks ago
Emil 'Tom' Frei III, MD, Eternal Optimist and Father of Combination Chemotherapy, Dies
TMC Net, 2 weeks ago
More from: EON, CNBC...and 3 other sources
|
bwt04292013CHICAGO For Avaxia Biologics Inc., the decision to attend BIO 2013 was a no-brainer. The Lexington, Mass.-based company is in the middle of a Phase Ib study of lead compound AVX-470, an orally administered anti-TNF polyclonal antibody, in ulcerative ... Pharmacy Choice, 2 weeks ago
|
Majority of children readmitted to hospital following stem cell transplantNearly two-thirds of children receiving stem cell transplants returned to the hospital within six months for treatment of unexplained fevers, infections or other problems, according to a study performed at Dana-Farber/Children's Hospital Cancer ... Brightsurf Science News, 3 weeks ago
|
COVER STORY: Global Biotech ReportScripps Research Institute in Palm Beach, FL From the March/April 2013 issue The recovery in the biotech sector appears to be solidifying. According to the most recent biotechnology report published by Ernst & Young, the sales in established biotech ... Business Facilities, 3 weeks ago
|
Voices Against Brain Cancer Comments on New Study Claiming Fat Tissue Stem Cells can Fight Brain Cancer, comments on a Medical Daily article where stem cells from fat tissue were used during brain surgery to chase cancer cells after the brain tumors were removed. According to the Medical Daily article by Ansa Varughese, the study showed that stem ... Digital Journal, 1 month ago
|
Dr. Harlan A. Levine to Serve as External Strategic Advisor for Quantum HealthQuantum Health is pleased to announce that Harlan A. Levine, M.D., is serving as an external strategic advisor to the company's Executive Team. In this role, Dr. Levine will provide counsel on strategy, anticipating and meeting market demands, and ... Individual.com, 1 month ago
More from: , Street Insider...and 5 other sources
|